Inactivation of OTUD6B almost completely eliminates the growth of multiple myeloma (MM) in vivo through cell cycle arrest at the G1/S checkpoint, which is consistent with the associated loss of MYC expression [14]. The gene discussed is OTUD6B; the disease is Miyoshi myopathy.